Heart · 2025-10-14
28 Hospital doctors’ knowledge of SGLT2 inhibitors in heart failure: a cross-specialty survey of awareness, side-effects, and perioperative management
Phrase rank #1 · DOI 10.1136/heartjnl-2025-ICS.28
Other observed topics
inhibitors
Observed in 56 articles across 21 journals.
Latest share0.04%
Change vs baseline-0.04 pp
Months observed12
Latest monthJul 2026
Portfolio article share
Attention over this snapshot
13 monthly points
Journal breadth
Where it appears
- Journal for ImmunoTherapy of Cancer16
- Heart7
- BMJ4
- BMJ Case Reports3
- BMJ Open3
- Journal of Neurology, Neurosurgery & Psychiatry3
- BMJ Oncology2
- BMJ Open Diabetes Research & Care2
- European Journal of Hospital Pharmacy2
- Gut2
- Journal of Scleroderma and Related Disorders2
- Archives of disease in childhood - Education & practice edition1
Co-occurrence
Explore nearby topics
Inspect the source signal
Article evidence
30 high-ranking examples
Lupus Science & Medicine · 2026-03-01
PO:11:292 Preclinical evaluation of IRF5 small molecule inhibitors with potent activity in lupus-relevant systems
Phrase rank #2 · DOI 10.1136/lupus-2026-el.345
BMJ Open · 2026-02-22
Comparative risk of the neurodegenerative outcomes between sodium-glucose co-transporter 2 (SGLT2) inhibitors and thiazolidinediones in type 2 diabetes: a multicentre cohort study using the Korean healthcare database (2014–2025)
Phrase rank #3 · DOI 10.1136/bmjopen-2025-105271
Archives of disease in childhood - Education & practice edition · 2025-09-18
How to use mTOR inhibitors in children
Phrase rank #3 · DOI 10.1136/archdischild-2024-327852
Journal for ImmunoTherapy of Cancer · 2025-11-04
1179 Discovery of a first-in-class ADAR1 p150 inhibitor targeting the Zα-domain with potent anti-tumor efficacy in syngeneic mouse models
Phrase rank #4 · DOI 10.1136/jitc-2025-SITC2025.1179
Thorax · 2025-11-02
S103 The effects of sodium/glucose co-transporter-2 (SGLT-2) inhibitors in COPD patients’ admission frequency, duration and use of acute NIV. A Single-Centre 48-month retrospective observational study in a UK tertiary care centre
Phrase rank #4 · DOI 10.1136/thorax-2025-BTSabstracts.109
BMJ · 2025-10-15
Sodium-glucose cotransporter-2 inhibitors and risk of autoimmune rheumatic diseases: population based cohort study
Phrase rank #4 · DOI 10.1136/bmj-2025-085196
Journal for ImmunoTherapy of Cancer · 2025-11-04
1071 SGLT2 inhibitor use and survival in solid tumors treated with immune checkpoint inhibitors: a real-world cohort study
Phrase rank #5 · DOI 10.1136/jitc-2025-SITC2025.1071
BMJ · 2025-10-15
SGLT-2 inhibitors for the prevention of autoimmune rheumatic diseases
Phrase rank #5 · DOI 10.1136/bmj.r2121
Heart · 2026-06-09
54 Cardiovascular safety of glucagon-like peptide-1 receptor agonists in real-world practice: a comparative phenotype-based analysis
Phrase rank #6 · DOI 10.1136/heartjnl-2026-BCS.237
BMJ Neurology Open · 2025-10-23
3694 Mito-bolic syndromes? A survey and literature review of diabetes in mitochondrial diseases
Phrase rank #6 · DOI 10.1136/bmjno-2025-ANZAN.204
RMD Open · 2026-05-07
Impact of biologic class and treatment line on psoriatic arthritis risk in psoriasis: a population-based cohort study
Phrase rank #7 · DOI 10.1136/rmdopen-2025-006687
BMJ · 2026-01-21
Adverse effects of proton pump inhibitors
Phrase rank #7 · DOI 10.1136/bmj.s95
Heart · 2025-12-08
P28 Ascertaining the potential for hypoglycaemia during exercise in cardiac patients on SGLT-2 inhibitors
Phrase rank #7 · DOI 10.1136/heartjnl-2025-BACPR.37
BMJ Case Reports · 2025-10-26
Pneumonitis: a serious adverse effect of PD-L1 inhibitors including pembrolizumab
Phrase rank #7 · DOI 10.1136/bcr-2018-224485
BMJ · 2025-08-20
Type 2 diabetes: SGLT-2 inhibitors to be offered as first line treatment in major guidance “shake-up”
Phrase rank #7 · DOI 10.1136/bmj.r1777
Journal of Scleroderma and Related Disorders · 2026-06-05
P.194 Raynaud’s phenomenon in the setting of immune checkpoint inhibitors: a case series and possible implications
Phrase rank #8 · DOI 10.1136/JSRD-2026-SSWC.238
European Journal of Hospital Pharmacy · 2026-06-03
Curcumin supplements in patients with breast cancer treated with CDK4/6 inhibitors: a silent pharmacokinetic risk
Phrase rank #8 · DOI 10.1136/ejhpharm-2026-005143
Journal for ImmunoTherapy of Cancer · 2026-02-04
Synergistic effects of anticoagulants and platelet aggregation inhibitors with immune checkpoint inhibitors in cancer therapy: a comprehensive review of preclinical and clinical evidence
Phrase rank #8 · DOI 10.1136/jitc-2025-013879
Frontline Gastroenterology · 2025-08-10
Iatrogenic effect of immune checkpoint inhibitors and targeted therapies on the lower gastrointestinal tract
Phrase rank #8 · DOI 10.1136/flgastro-2025-103094
BMJ Open Gastroenterology · 2026-07-13
Selective COX-2 inhibitors for short-term musculoskeletal pain in inflammatory bowel disease in remission: a narrative review
Phrase rank #9 · DOI 10.1136/bmjgast-2026-002316
European Journal of Hospital Pharmacy · 2026-03-18
4CPS-015 Pharmacist’s role in the follow-up of patients treated with PCSK9i inhibitors
Phrase rank #9 · DOI 10.1136/ejhpharm-2026-eahp.120
BMJ Oncology · 2026-01-28
Impact of immunotherapy and small molecule cancer therapy on fertility: a narrative review of current evidence, mechanisms and future directions
Phrase rank #9 · DOI 10.1136/bmjonc-2025-000843
BMJ Open · 2025-12-07
Are hypertensive women with type 2 diabetes treated with RAS inhibitors as often as men? A cross-sectional study in France
Phrase rank #9 · DOI 10.1136/bmjopen-2024-092205
Heart · 2025-08-13
BS06 Structural insights into SMURF1 inhibitions and its therapeutic potential in pulmonary arterial hypertension
Phrase rank #9 · DOI 10.1136/heartjnl-2025-BCS.238
BMJ Case Reports · 2026-06-15
Rho-kinase inhibitors predisposing to secondary keratitis
Phrase rank #10 · DOI 10.1136/bcr-2025-270525
Heart · 2026-05-08
Methodological lessons of implementation trials in heart failure
Phrase rank #10 · DOI 10.1136/heartjnl-2026-328160
Journal for ImmunoTherapy of Cancer · 2025-11-28
International real-world study of combination immunotherapy sequences in metastatic melanoma
Phrase rank #10 · DOI 10.1136/jitc-2025-012225
Journal for ImmunoTherapy of Cancer · 2025-11-04
403 Machine learning-based prediction of adverse events in cancer patients treated with PD-1/PD-L1 inhibitors using FAERS data
Phrase rank #10 · DOI 10.1136/jitc-2025-SITC2025.0403
BMJ Open Diabetes Research & Care · 2025-08-07
Association between dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists and COVID-19 infection and adverse outcomes: a cohort study
Phrase rank #10 · DOI 10.1136/bmjdrc-2024-004677